Despite the importance of age, gender, and race/ethnicity representativeness in clinical trials, limited data exist regarding the enrollment trends of these groups in heart failure trials. A systematic search of contemporary heart failure trials found that older patients and women are consistently underrepresented (women were 27%), but the enrollment of nonwhite patients increased over time.